FeesSafety
Pluang+

Polymarket launches leveraged perpetual futures, risking small traders with 20x leverage on $90T market.

Market News
06 Sep 2026, 15:45 WIB
24/7 Wall Street
View Source
Neutral
Polymarket launches leveraged perpetual futures, risking small traders with 20x leverage on $90T market.

Polymarket has introduced perpetual futures with up to 20x leverage, allowing small retail traders to control large positions in assets like crypto, stocks, and commodities. This market, with over $90 trillion in global volume, offers huge opportunities but also significant risks, as a 5% adverse move can wipe out an entire margin. Polymarket's typical user trades small amounts, making the high leverage especially dangerous. Investors should be cautious, as the math behind leverage means surviving market moves is as important as being right about them.

More News

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...

Company Fundamentals
Bullish
55 minutes ago
UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...

Neutral
55 minutes ago
Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App